Found: 49
Select item for more details and to access through your institution.
The role of DPYD and the effects of DPYD suppressor luteolin combined with 5‐FU in pancreatic cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 16, p. 1, doi. 10.1002/cam4.70124
- By:
- Publication type:
- Article
A retrospective comparative study of S-IROX and modified FOLFIRINOX for patients with advanced pancreatic cancer refractory to gemcitabine plus nab-paclitaxel.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 605, doi. 10.1007/s10637-020-01022-0
- By:
- Publication type:
- Article
A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 338, doi. 10.1007/s10637-018-0691-9
- By:
- Publication type:
- Article
A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1294, doi. 10.1007/s10637-013-9972-5
- By:
- Publication type:
- Article
TRAIL-induced cell death cooperates with IFN-γ activation in the graft- versus-tumor effect against colon tumors.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 9, p. 2237, doi. 10.1002/ijc.21658
- By:
- Publication type:
- Article
Inhibition of histone methyltransferase G9a attenuates liver cancer initiation by sensitizing DNA-damaged hepatocytes to p53-induced apoptosis.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41419-020-03381-1
- By:
- Publication type:
- Article
Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1.
- Published in:
- Nature Communications, 2016, v. 7, n. 9, p. 13006, doi. 10.1038/ncomms13006
- By:
- Publication type:
- Article
Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-ß.
- Published in:
- Oncogene, 2005, v. 24, n. 4, p. 662, doi. 10.1038/sj.onc.1208102
- By:
- Publication type:
- Article
Smad4-independent regulation of p21/WAF1 by transforming growth factor-ß.
- Published in:
- Oncogene, 2004, v. 23, n. 5, p. 1043, doi. 10.1038/sj.onc.1207222
- By:
- Publication type:
- Article
A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer.
- Published in:
- Oncology, 2009, v. 77, n. 5, p. 300, doi. 10.1159/000259616
- By:
- Publication type:
- Article
Smad4 is Essential for Down-regulation of E-cadherin Induced by TGF-β in Pancreatic Cancer Cell Line PANC-1.
- Published in:
- Journal of Biochemistry, 2007, v. 141, n. 3, p. 345, doi. 10.1093/jb/mvm039
- By:
- Publication type:
- Article
Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55211-w
- By:
- Publication type:
- Article
Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2020, v. 17, n. 6, p. 695, doi. 10.21873/cgp.20224
- By:
- Publication type:
- Article
Photoacoustic Tomography of Human Hepatic Malignancies Using Intraoperative Indocyanine Green Fluorescence Imaging.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0112667
- By:
- Publication type:
- Article
Corrigendum: A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion.
- Published in:
- Scientific Reports, 2017, p. 39567, doi. 10.1038/srep39567
- By:
- Publication type:
- Article
A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion.
- Published in:
- Scientific Reports, 2016, p. 23899, doi. 10.1038/srep23899
- By:
- Publication type:
- Article
Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 11, p. 2404, doi. 10.1093/carcin/bgu136
- By:
- Publication type:
- Article
Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells.
- Published in:
- Carcinogenesis, 2013, v. 34, n. 10, p. 2380, doi. 10.1093/carcin/bgt174
- By:
- Publication type:
- Article
Inhibition of transforming growth factor-β signaling in myeloid cells ameliorates aortic aneurysmal formation in Marfan syndrome.
- Published in:
- PLoS ONE, 2020, v. 15, n. 11, p. 1, doi. 10.1371/journal.pone.0239908
- By:
- Publication type:
- Article
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
The inhibition of renin-angiotensin system in advanced pancreatic cancer: an exploratory analysis in 349 patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 5, p. 933, doi. 10.1007/s00432-014-1873-2
- By:
- Publication type:
- Article
Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-78320-3
- By:
- Publication type:
- Article
A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of S-1 in Patients with Gemcitabine-refractory Pancreatic Cancer in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 8, p. 774, doi. 10.1093/jjco/hyq059
- By:
- Publication type:
- Article
Regulation of the hedgehog signaling by the mitogen-activated protein kinase cascade in gastric cancer.
- Published in:
- Molecular Carcinogenesis, 2009, v. 48, n. 8, p. 703, doi. 10.1002/mc.20516
- By:
- Publication type:
- Article
Targeting mutated KRAS in the first‐line therapy.
- Published in:
- Clinical & Translational Discovery, 2024, v. 4, n. 2, p. 1, doi. 10.1002/ctd2.291
- By:
- Publication type:
- Article
Blocking CXCLs–CXCR2 axis in tumor–stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invasion/migration and a shift of immune-inflammatory microenvironment.
- Published in:
- Oncogenesis, 2019, v. 8, n. 2, p. 1, doi. 10.1038/s41389-018-0117-8
- By:
- Publication type:
- Article
Single small-interfering RNA expression vector for silencing multiple transforming growth factor-β pathway components.
- Published in:
- Nucleic Acids Research, 2005, v. 33, n. 15, p. e131, doi. 10.1093/nar/gni130
- By:
- Publication type:
- Article
Reduced p38 mitogen-activated protein kinase in donor grafts accelerates acute intestinal graft-versus-host disease in mice.
- Published in:
- European Journal of Immunology, 2005, v. 35, n. 7, p. 2210, doi. 10.1002/eji.200425897
- By:
- Publication type:
- Article
Significance of Tumor Microenvironment for Regulating Pancreatic Cancer.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4880, doi. 10.3390/cancers14194880
- By:
- Publication type:
- Article
The Role of the Microbiome in Pancreatic Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184479
- By:
- Publication type:
- Article
The Role of Neural Signaling in the Pancreatic Cancer Microenvironment.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4269, doi. 10.3390/cancers14174269
- By:
- Publication type:
- Article
A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 911, doi. 10.1007/s00280-014-2563-0
- By:
- Publication type:
- Article
A retrospective analysis of early CA199 change in salvage chemotherapy for refractory pancreatic cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
A retrospective analysis of early CA19-9 change in salvage chemotherapy for refractory pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1291, doi. 10.1007/s00280-013-2313-8
- By:
- Publication type:
- Article
A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 5, p. 985, doi. 10.1007/s00280-013-2278-7
- By:
- Publication type:
- Article
Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 85, doi. 10.1007/s00280-012-1981-0
- By:
- Publication type:
- Article
A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age.
- Published in:
- Journal of Gastroenterology, 2013, v. 48, n. 2, p. 238, doi. 10.1007/s00535-012-0622-z
- By:
- Publication type:
- Article
Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression.
- Published in:
- Journal of Gastroenterology, 2012, v. 47, n. 2, p. 203, doi. 10.1007/s00535-011-0482-y
- By:
- Publication type:
- Article
Reduced expression of RAS protein activator like-1 in gastric cancer.
- Published in:
- International Journal of Cancer, 2011, v. 128, n. 6, p. 1293, doi. 10.1002/ijc.25459
- By:
- Publication type:
- Article
HNF1B‐driven three‐dimensional chromatin structure for molecular classification in pancreatic cancers.
- Published in:
- Cancer Science, 2023, v. 114, n. 4, p. 1672, doi. 10.1111/cas.15690
- By:
- Publication type:
- Article
Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1.
- Published in:
- Cancer Science, 2018, v. 109, n. 11, p. 3602, doi. 10.1111/cas.13784
- By:
- Publication type:
- Article
Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer.
- Published in:
- Cancer Science, 2013, v. 104, n. 3, p. 337, doi. 10.1111/cas.12080
- By:
- Publication type:
- Article
Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1.
- Published in:
- Cancer Science, 2012, v. 103, n. 8, p. 1489, doi. 10.1111/j.1349-7006.2012.02311.x
- By:
- Publication type:
- Article
Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.
- Published in:
- Cancer Science, 2012, v. 103, n. 4, p. 670, doi. 10.1111/j.1349-7006.2012.02213.x
- By:
- Publication type:
- Article
Analysis of the β-Catenin/T Cell Factor Signaling Pathway in 36 Gastrointestinal and Liver Cancer Cells.
- Published in:
- Cancer Science, 2002, v. 93, n. 11, p. 1213, doi. 10.1111/j.1349-7006.2002.tb01226.x
- By:
- Publication type:
- Article
Frameshift Mutations at Mononucleotide Repeats in RAD50 Recombinational DNA Repair Gene in Colorectal Cancers with Microsatellite Instability.
- Published in:
- Cancer Science, 2001, v. 92, n. 6, p. 587, doi. 10.1111/j.1349-7006.2001.tb01134.x
- By:
- Publication type:
- Article